Increasing transparency and accountability in national pharmaceutical systems

Access to safe, effective, good-quality medicines can be compromised by poor pharmaceutical system governance. This system is particularly vulnerable to inefficiencies and to losses from corruption, because it involves a complex mix of actors with diverse responsibilities. A high level of transparen...

Descripción completa

Detalles Bibliográficos
Autores principales: Paschke, Anne, Dimancesco, Deirdre, Vian, Taryn, Kohler, Jillian C, Forte, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2018
Materias:
Policy & Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239016/
https://www.ncbi.nlm.nih.gov/pubmed/30455533
http://dx.doi.org/10.2471/BLT.17.206516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239016/
https://www.ncbi.nlm.nih.gov/pubmed/30455533
http://dx.doi.org/10.2471/BLT.17.206516

Ejemplares similares